scholarly journals The Effects of App-Delivered Cognitive Behavioral Therapy for Insomnia (CBT-I) on Sleep Quality, Dysfunctional Beliefs, and Sleep Hygiene

2020 ◽  
Vol 25 (3) ◽  
pp. 224-234
Author(s):  
Julia A. Leonard ◽  
Angela B. Duncan
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Sleep Quality ◽  
Behavioral Therapy ◽  
Sleep Hygiene ◽  
Cognitive Behavioral ◽  
Dysfunctional Beliefs

scholarly journals Efficacy of cognitive-behavioral therapy for insomnia: a group format implementation in the Spanish National Health System

2021 ◽  
Vol 26 (3) ◽  
pp. 173-180
Author(s):  
Paula Lantarón-Imedio ◽  
Mª Rosario Pina-Camacho ◽  
Marcos L. Moya-Diago ◽  
Belén Pascual-Vera ◽  
César Mateu ◽  
...  
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Health System ◽  
Behavioral Therapy ◽  
National Health System ◽  
Cognitive Behavioral ◽  
Dysfunctional Beliefs ◽  
Group Format ◽  
Insomnia Disorder ◽  
Spanish National Health System ◽  
Beliefs And Attitudes

Background. Cognitive-behavioral therapy for insomnia (CBT-i) is considered the first-line treatment for this disorder, but it is not widely implemented in clinical settings. This study aims to examine the efficacy of a CBT-i in group format in the Spanish National Health System. Method. Fifty-two participants with a Primary Insomnia Disorder (55.8% women; Mage = 47.19, SD = 11.02) were assigned to a CBT-i (n =17) or waiting list condition (n = 21). Treatment consisted of eight group format sessions (2 hours/week). Results. Significant improvements in insomnia severity, sleep quality, and insomnia-related dysfunctional beliefs and attitudes were observed in patients who received CBT-i. Emotional symptoms also decreased after the intervention in the CBT-i group. Conclusion. Findings support the efficacy of cognitive-behavioral therapy for insomnia with a group protocol for patients with primary insomnia disorder. The maintenance role of insomnia-related dysfunctional beliefs and attitudes in this disorder is also suggested.

scholarly journals Positive Effects of Laser Acupuncture in Methamphetamine Users Undergoing Group Cognitive Behavioral Therapy: A Pilot Study

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Yi-Hsien Shiao ◽  
Yi-Chih Chen ◽  
Yuan-Chieh Yeh ◽  
Tse-Hung Huang
Keyword(s):  
Liver Function ◽  
Cognitive Behavioral Therapy ◽  
Sleep Quality ◽  
Addiction Treatment ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Health Concern ◽  
Laser Acupuncture ◽  
Positive Effects ◽  
Significant Difference

Background. Methamphetamine (MA) addiction has become a crucial public health concern because of its adverse consequences to individuals and the society. Objective. To investigate the clinical efficacy of laser acupuncture combined with group cognitive behavioral therapy for MA addiction treatment. Materials and Methods. MA users who participated in group cognitive behavioral therapy and met the inclusion criteria were referred from psychiatrists to participate. The participants received laser acupuncture treatment once a week for 2 months (total eight treatments) on selected acupoints (PC6, HT7, LI4, ST36, SP6, and LR3). Laboratory assessment included urinalysis for MA and liver function tests aspartate aminotransferase, alanine aminotransferase, and γ-glutamyltransferase (AST, ALT, and γ-GT), whereas the objective assessment included visual analog scale (VAS) for MA craving and refusal and Pittsburgh sleep quality index (PSQI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) questionnaires. All data were collected before and at 1 and 2 months after treatment. Cognitive behavioral therapy completion rate and rate of relapse to MA use were also determined. Result. Fifteen participants were enrolled, of whom seven completed the trial. Urinalysis for MA revealed a decrease in drug use from 57.1% to 28.6%. Compared with those before treatment, PSQI scores were significantly lower at 1 and 2 months after treatment (−3.73 and −4.10, respectively; both p < 0.001 ), and so were BDI scores (−5.64 and −8.17, respectively; p = 0.01 and 0.001, respectively). However, no significant difference was observed in the liver function test, VAS of craving and refusal, and BAI results. A slight improvement in the motivation for drug abstinence and anxiety was observed during the treatment course. Participants reported no adverse events. Conclusion. Laser acupuncture combined with group cognitive behavioral therapy may improve sleep quality, alleviate depression, and reduce MA use. Additional large-scale studies confirming the effectiveness of this modality are warranted.

scholarly journals A Pilot Randomized Controlled Trial to Assess Feasibility and Treatment Effect of a Web-Based Delivered Cognitive Behavioral Therapy for Insomnia Program in Individuals with Multiple Sclerosis

2020 ◽  
Author(s):  
Catherine F. Siengsukon ◽  
Eber Silveira Beck ◽  
Michelle Drerup
Keyword(s):  
Multiple Sclerosis ◽  
Cognitive Behavioral Therapy ◽  
Sleep Quality ◽  
Treatment Effect ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Chronic Insomnia ◽  
Web Based ◽  
Phone Calls ◽  
Insomnia Severity

Abstract Background: At least 40% of individuals with multiple sclerosis (MS) experience chronic insomnia. Recent studies indicate that cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for insomnia symptoms in individuals with MS. CBT-I delivered using web-based applications has been shown to be effective and may increase access to CBT-I for individuals with MS who have mobility difficulties, fatigue, or live in rural areas. Therefore, the purpose of this study was to assess the feasibility and treatment effect of CBT-I delivered using a web-based application with or without biweekly phone calls to improve sleep quality and fatigue in individuals with MS and symptoms of insomnia. Methods: Forty-one individuals with MS and symptoms of insomnia were randomized into either a group that participated in a 6-week web-based CBT-I program (wCBT-I) or a group that participated in a web-based CBT-I program and received biweekly support phone calls (wCBT-I+PC). Participants completed surveys online to assess insomnia severity, sleep quality, fatigue, sleep self-efficacy, depression, anxiety, and motivation to change their sleep behavior. Results: The overall retention rate was 48.8%, and the adherence rate was 96.34%. Both groups had a significant improvement in insomnia severity, sleep quality, anxiety, and sleep self-efficacy. Only the wCBT-I group had a significant improvement in depression and fatigue. Conclusions: Web-delivered CBT-I is feasible and effective in improving sleep outcomes and concomitant symptoms in individuals with MS. Web-based CBT-I may increase the accessibility of CBT-I treatment and provide a stepped-care approach to treating chronic insomnia in individuals with MS.

Treating depression with a smartphone-delivered self-help cognitive behavioral therapy for insomnia: A parallel-group randomized controlled trial

2021 ◽  
Author(s):  
Christian Shaunlyn Chan ◽  
Christy Wong ◽  
Branda Y. M. Yu ◽  
Victoria Ka-Ying Hui ◽  
Fiona Y. Y. Ho ◽  
...  
Keyword(s):  
Major Depression ◽  
Cognitive Behavioral Therapy ◽  
Sleep Quality ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Cognitive Behavioral ◽  
Treatment Difference ◽  
Self Help ◽  
Parallel Group

Background: Despite its efficacy in treating comorbid insomnia and depression, cognitive behavioral therapy for insomnia (CBT-I) is limited in its accessibility and, in many regions, cultural compatibility. Smartphone-based treatments is a low-cost, convenient alternative modality. This study evaluated a self-help smartphone-based CBT-I in alleviating major depression and insomnia.Methods: A parallel-group randomized, waitlist-controlled trial was conducted with 322 adults with major depression and insomnia. Participants were randomized to receive either a 6-week CBT-I via a smartphone application, proACT-S, or waitlist condition. The primary outcomes included depression severity, insomnia severity, and sleep quality. The secondary outcomes included anxiety severity, subjective health, and acceptability of treatment. Assessments were administered at baseline, post-intervention follow up (Week 6), and Week 12 follow-up. The waitlist group received treatment after the first follow-up.Results: Intention to treat analysis was conducted with multilevel modeling. In all but one models, the interaction between treatment condition and the time point at Week 6 follow-up was significant. Compared with the waitlist group, the treatment group had lower levels of depression (CES-D: treatment difference = 0.83, 95% CI [0.58, 1.09]), insomnia (ISI: treatment difference = 0.89, 95% CI [0.64, 1.16]), and anxiety (HADS-A: treatment difference = 0.80, 95% CI [0.55, 1.06]). They also had better sleep quality (PSQI: treatment difference = 0.84, 95% CI [0.58, 1.10]). No differences across any measures were found at Week 12, after the waitlist control group received the treatment. Conclusion: proACT-S is an efficacious sleep-focused self-help treatment for major depression and insomnia.

Sign in / Sign up

Export Citation Format

Share Document